US 2012/0059058 A1Published application

Dispersions of rasagiline citrate

AssigneeTeva Pharmaceutical Industries Ltd.

InventorsKeith Lorimer, David Engers

Life of this patent

Estimating the term…

The subject invention provides a solid dispersion of rasagiline citrate, a composition and a process for the manufacture thereof.

Dependent claims

A solid dispersion of at least one polymeric pharmaceutical excipient and rasagiline or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

A61K 47/32
Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates: macromolecular compounds obtained by reactions only involving…
A61K 9/1635
Organic macromolecular compounds: obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, polyacrylates
A61K 9/1652
Organic macromolecular compounds: polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
A61K 9/19
Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles: lyophilised , i.e.…

From the US filing history. Foreign family members aren’t listed.

Loading patent…